Compare ImmunityBio Inc. Common Stock (IBRX) vs LifeStance Health Group Inc. Common Stock (LFST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ImmunityBio Inc. Common Stock vs LifeStance Health Group Inc. Common Stock — how do they compare? ImmunityBio Inc. Common Stock trades at $10.41 (market cap $10.51B), while LifeStance Health Group Inc. Common Stock trades at $12.37 (market cap $4.58B). The key difference: ImmunityBio Inc. Common Stock is far larger — about 2.3× LifeStance Health Group Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is more actively traded (10,445,785 versus 2,356,698). Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and LifeStance Health Group Inc. Common Stock for 0 Days on average.
| IBRX | LFST | |
|---|---|---|
Market Cap | $10.51B | $4.58B |
Volume | 10,445,785 | 2,356,698 |
Sector | Health | Health |
52-Week High | $11.55 | $13.38 |
52-Week Low | $1.98 | $4.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.97B | $4.82B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →About LifeStance Health Group Inc. Common Stock
LifeStance Health provides outpatient mental healthcare, including therapy, psychiatry, and medication management services.
Read more on LFST →
